Journal of Virology · 2018 · 31 citations · 67 references
Life SciencesMolecular BiologyOncologyEpigeneticsEpigenomicsMolecular OncologyCancer EpigeneticsCancer EpigenomicsDna Methylation ProfilingEpigenetic Regulation In CancerKaposi SarcomaOncogenic VirusesGenome-wide Methylation AnalysisHuman Herpesvirus 8Methylation ArraysPrimary Effusion LymphomaPromoter Cpg MethylationPromoter HypermethylationPromotersViral Promoters
In cancer cells, certain promoters become aberrantly methylated, contributing to the phenotype of the tumor. KSHV infection seems to modify cellular CpG methylation, but only a few methylated promoters have been identified in KSHV-infected cells. Here, we investigated the CpG methylation of the human genome in KSHV-associated primary effusion lymphoma (PEL) and KSHV-infected cells. We have identified many hyper- and hypomethylated gene promoters and correlated their methylation with cellular gene expression. These differentially methylated cellular promoters can distinguish KSHV-positive cells from uninfected cells and may serve as the foundation for the use of these differentially methylated regions as potential biomarkers for KSHV-associated malignancies. Drugs that reverse these cancerous methylation patterns have the potential to inhibit tumor growth. Here, we show that treating PEL cells with a demethylating drug (5-aza-2'-deoxycytidine) led to inhibition of cell growth, raising the possibility of testing this drug for the treatment of PEL.
67